Practicing pediatrician’s perspective on the immunization schedules: a short survey


  • Jagannathan S. Department of Pediatrics, Government Dharmapuri Medical College, Dharmapuri, Tamil Nadu, India
  • Kumaravel K. S. Department of Pediatrics, Government Dharmapuri Medical College, Dharmapuri, Tamil Nadu, India
  • Rameshbabu B. Department of Pediatrics, Government Dharmapuri Medical College, Dharmapuri, Tamil Nadu, India



IAP, Immunization schedule, Vaccination


Background: The practicing pediatrician is left in a dilemma regarding the need for the newer vaccines and conflicting scientific data from vaccine manufacturers. This study is aimed at evaluating the pediatrician’s perspective regarding the immunization schedule.

Methods: A brief questionnaire was framed to bring out the most common issues faced by the pediatrician in immunization schedules.

Results: About 77 percent of respondents felt that our National Immunization is inadequate. About 37 percent and 28 percent of respondents felt that the next vaccine that is to be introduced in the National Immunization Schedule is Pneumococcal vaccine and Rotavirus vaccine respectively. Nearly half of the respondents trusted IAP as the single most important influencing factor in choosing a newer vaccine. About 76 percent of respondents felt that the immunization schedules are influenced by vaccine makers

Conclusions: The practicing pediatrician who had always looked at IAP Immunization schedule as his bible in office practice is now beginning to doubt its authenticity. The threat of not having a consensus on Immunization is detrimental. It is the duty of IAP to clear the air regarding the controversies it had faced in the immunization schedule.


The time line of vaccines. Available at accessed on 29/04/2017.

WHO, UNICEF, World Bank. State of the world’s vaccines and immunization, 3rd ed. Geneva, World Health Organization; 2009.

New Delhi: Ministry of Health and Family Welfare, Government of India; 2005. Government of India. Report of National Universal Immunization Program review; 2004.

Singru SA. Controversies in vaccination scene in India. Int J Contemp Pediatr. 2017;1(1):1-2.

CP Bansal, IAP’s Perspectives on Current Vaccination Scenario in India, Indian Pediatr. 2013;50:911-2.

Shrabonti B, The vaccine and its controversy. Available from: http://timesof controversy/articleshow/34130024.cms?.

Nagarajan R. Non-mandatory vaccines for babies: A hefty dose of profit. Available from:

Nagarajan R. Conflict of interest on recommendation of immunization schedule? Available from:

Vashishtha VM. The nexus and the ills afflicting the vaccination practices. Indian J Med Res. 2008;127:502-3.

Jacob J. Vaccination policy for benefit and profit, public and private, Indian J Med Res. 2008;127:498-501.

Nisarga R, Premlatha R, Shivanada, Ravikumar KL, Shivappa U, Gopi A, et al. Hospital-based surveillance of invasive pneumococcal disease and pneumonia in South Bangalore, India. Indian Pediatr. 2015;52:205-11.

Khan G, Fitzwater S, Tate J. Epidemiology and prospects for prevention of Rotavirus Diseases in India. Ind Pediatr. 2012;49:467-74.

Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatr. 2013;131(6):e1716-22.

Long SS, Deforest A, Smith DG, Lazaro C, Wassilak GF. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatr. 1990;85(3):294-302.

Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308(20):2126-32.

Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997 Mar 28;46(RR-7):1-25.

Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3(3):183-8.

Shapiro ED. Acellular vaccines and resurgence of pertussis. JAMA. 2012;308(20):2149-50.

Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730-5.

Vashishtha V. Vaccine nexus: Whistleblower Bengaluru pediatrician seeks police help, City News Bangalore. Available at






Original Research Articles